Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.53 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.53 |
| ▸ | CNR1 | P21554 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.48 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4022986 | 0.87 | EPHX2 (0.51) | CNR2ALDH1A1HPGDKMT2AKEAP1 | |
| SCHEMBL5472631 | 0.85 | CNR2 (0.55) | CNR2ALDH1A1HPGDKMT2AKEAP1 | |
| SCHEMBL14011511 | 0.81 | CNR2 (0.65) | CNR2ALDH1A1HPGDKMT2AKEAP1 | |
| SCHEMBL27183469 | 0.80 | SLC1A2 (0.47) | HPGDKEAP1NFE2L2CYP2D6 | |
| SCHEMBL27183468 | 0.80 | SLC1A2 (0.47) | HPGDKEAP1NFE2L2CYP2D6 | |
| SCHEMBL8885963 | 0.80 | ALDH1A1 (0.81) | CNR2ALDH1A1HPGDKMT2ACNR1 | |
| SCHEMBL18822674 | 0.78 | CNR2 (0.61) | CNR2ALDH1A1HPGDKMT2AKEAP1 | |
| SCHEMBL7855746 | 0.77 | CNR2 (0.69) | CNR2ALDH1A1HPGDKMT2ACNR1 | |
| SCHEMBL11335722 | 0.77 | CNR2 (0.69) | CNR2ALDH1A1HPGDKMT2ACNR1 | |
| SCHEMBL11665352 | 0.76 | CNR2 (1.00) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070060480-A1 | Heteroaroyl-substituted phenylalanineamides | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | disclosed |
| EP-1716120-A1 | HERBICIDAL HETEROAROYL-SUBSTITUTED PHENYLALANINE AMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-02 | — | — | EP | disclosed |
| WO-2005061464-A1 | HERBICIDAL HETEROAROYL-SUBSTITUTED PHENYLALANINE AMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060480-A1 | Heteroaroyl-substituted phenylalanineamides | PAH, PM20D2, FARSA | CNR2 2586/4885ALDH1A1 2661/4885HPGD 3026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.